Mosunetuzumab-Axgb Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 mg/mL
Reference Brands: Lunsumio (USA/EU)
Category: Oncology Cancer Care
Mosunetuzumab-axgb is a bispecific CD20-directed CD3 T-cell engager. It binds CD20 on B-cells and CD3 on T-cells, bringing T-cells into proximity with cancerous B-cells so the immune system can attack and destroy them. It is used to treat adult patients with relapsed or refractory Follicular Lymphoma (a type of non-Hodgkin B-cell lymphoma) after they have had at least two prior systemic therapies. mosunetuzumab-axgb is available in Injection and strengths such as 1 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, mosunetuzumab-axgb is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
mosunetuzumab-axgb can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Mosunetuzumab-axgb is used to treat relapsed or refractory follicular lymphoma in adults who have received at least two prior systemic therapies.
Mosunetuzumab-axgb is a bispecific monoclonal antibody designed to bind both CD20 on B-cells and CD3 on T-cells, directing the immune system to destroy malignant B-cells.
The trade name is Lunsumio.
Lunsumio is manufactured by Genentech, a member of the Roche Group.
The generic name is mosunetuzumab-axgb.
The brand name is Lunsumio.
It is manufactured in the United States and Europe by Genentech/Roche.
Related Products
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Nintedanib
Strength:
100 mg, 150 mg
Form: Capsules
Reference Brands: Ofev (USA, EU), Vargatef (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
